Biogen Inc. buy Haans
Start price
19.07.16
/
50%
€236.03
Target price
02.08.16
€280.00
Performance (%)
23.10%
End price
02.08.16
€290.55
Summary
This prediction ended on 02.08.16 with a price of €290.55. The BUY prediction by Haans finished with a performance of 23.10%. Haans has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | -3.457% | -3.457% | 2.089% | -45.522% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by Haans for this prediction
In the thread Biogen Inc. diskutieren
Gewinnt an Stärke...
Biogen, wie auch der gesamte Biotech-Sektor gewinnt deutlich an Stärke. Biotech wird bald wieder zu den Outperformern gehören. Es ist an der Zeit sich langsam zu positionieren.